Active surveillance is cost-effective compared with standard surgery among esophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy
1. Active surveillance was cost-effective over 5 years compared with standard surgery in patients with esophageal cancer and complete clinical ...